SCHEMBL20449072

SCHEMBL20449072

CC(=O)Nc1ccc(Br)nc1NCC(C)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.37
CYP2D6 P10635 1/20 0.37
ALDH1A1 P00352 4/20 0.36
MAPT P10636 3/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
PGK1 P00558 1/20 0.35
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 2/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17018046 0.75 RXFP1 (0.37) RXFP1CYP2D6ALDH1A1MAPTCA1
SCHEMBL16722792 0.75 CFTR (0.39) ALDH1A1MAPTNPC1RAB9AKDM4E
SCHEMBL20449062 0.72 HDAC1 (0.45) RXFP1ALDH1A1MAPTCA1CA2
SCHEMBL20449070 0.71 CA1 (0.46) RXFP1ALDH1A1MAPTCA1CA2
SCHEMBL20449079 0.69 RXFP1 (0.45) RXFP1ALDH1A1MAPTCA1CA2
SCHEMBL25960696 0.68 DYRK1A (0.38) ALDH1A1MAPTPGK1LMNATSHR
SCHEMBL23213942 0.67 ALDH1A1 (0.40) ALDH1A1LMNANPC1RAB9AKDM4E
SCHEMBL31149384 0.67 DYRK1A (0.40) ALDH1A1MAPTCA1CA2CA9
SCHEMBL29844628 0.67 ALDH1A1 (0.40) ALDH1A1LMNANPC1RAB9AKDM4E
SCHEMBL16722340 0.67 KMT2A (0.40) RXFP1CYP2D6ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180273528-A1 IMIDAZO[4,5-b]PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2018-09-27 US disclosed
EP-3356363-A1 NEW IMIDAZO[4,5-B]PYRIDINE DERIVATIVES AS DUAL DYRK1/CLK1 INHIBITORS Les Laboratoires Servier (FR) 2018-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180273528-A1 IMIDAZO[4,5-b]PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM IDH2, CYP4B1, RB1 RXFP1 1652/4885CYP2D6 113/4885ALDH1A1 410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.